Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor of Peripheral Nerve”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01946529
What this trial is testing

Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors

Who this might be right for
Desmoplastic Small Round Cell TumorEwing Sarcoma of Bone or Soft TissueLocalized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor+1 more
St. Jude Children's Research Hospital 24
Early research (Phase 1)Study completedNCT00036959
What this trial is testing

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
National Institutes of Health Clinical Center (CC) 90
Early research (Phase 1)Ended earlyNCT04751383
What this trial is testing

Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma

Who this might be right for
High Risk NeuroblastomaRecurrent NeuroblastomaRecurrent Osteosarcoma+2 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)UnknownNCT03741101
What this trial is testing

Treatment of NF1-related Plexiform Neurofibroma With Trametinib

Who this might be right for
Neurofibromatosis 1ChildNeurofibroma, Plexiform
Region Skane 15
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)UnknownNCT00281905
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastoma
Children's Cancer and Leukaemia Group 50
Not applicableUnknownNCT03097822
What this trial is testing

Response Prediction After GKS in Patients With Vestibular Schwannoma Using DCE MR Imaging

Who this might be right for
Vestibular Schwannoma
Seoul National University Hospital 90
Testing effectiveness (Phase 2)Looking for participantsNCT07318831
What this trial is testing

Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in Children

Who this might be right for
Neuroblastoma (NB)Neuroblastoma in Children
Tianjin Medical University Cancer Institute and Hospital 27
Not applicableActive Not RecruitingNCT03496402
What this trial is testing

Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO)

Who this might be right for
NeuroblastomaRhabdomyosarcomaEwing Sarcoma Family of Tumors+3 more
Institut Curie 600
Not applicableUnknownNCT04128345
What this trial is testing

Novel Multimodality Imaging for Navigation in Skull Base Surgery

Who this might be right for
Vestibular Schwannoma
University College, London 20
Not applicableStudy completedNCT02786719
What this trial is testing

High-Risk Neuroblastoma Chemotherapy Without G-CSF

Who this might be right for
Neuroblastoma
Baylor College of Medicine 13
Testing effectiveness (Phase 2)Looking for participantsNCT06188741
What this trial is testing

Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1

Who this might be right for
Neurofibromatosis 1Plexiform Neurofibroma
University of Alabama at Birmingham 200
Testing effectiveness (Phase 2)WithdrawnNCT00003273
What this trial is testing

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastomaRetinoblastoma+1 more
NYU Langone Health
Testing effectiveness (Phase 2)Ended earlyNCT00003513
What this trial is testing

Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Burzynski Research Institute 3
Not applicableStudy completedNCT03638310
What this trial is testing

Role of Psychiatric Profile in Prehabituated Patients After Vestibular Schwannoma Surgery

Who this might be right for
Vestibular SchwannomaVestibular Function Disorder
Charles University, Czech Republic 37
Testing effectiveness (Phase 2)Study completedNCT00004110
What this trial is testing

Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06277154
What this trial is testing

MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma

Who this might be right for
LeiomyosarcomaLiposarcomaSynovial Sarcoma+8 more
HRYZ Biotech Co. 148
Early research (Phase 1)Study completedNCT01625351
What this trial is testing

CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

Who this might be right for
Ewing SarcomaGastrointestinal TumorGerm Cell Tumor+10 more
St. Jude Children's Research Hospital 23
Testing effectiveness (Phase 2)Looking for participantsNCT04936529
What this trial is testing

A Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 286
Testing effectiveness (Phase 2)Study completedNCT02452554
What this trial is testing

Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma

Who this might be right for
Pleuropulmonary BlastomaRecurrent Malignant Peripheral Nerve Sheath TumorRecurrent Neuroblastoma+3 more
Children's Oncology Group 62
Next Page